期刊
EXPERT OPINION ON THERAPEUTIC TARGETS
卷 10, 期 5, 页码 703-708出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.10.5.703
关键词
anoikis; apoptosis; caspase 8; metastasis; neuroblastoma
资金
- Intramural NIH HHS Funding Source: Medline
The clinical challenge in neuroblastoma is the presence of metastasis at diagnosis in the majority of patients. Caspase 8 is an integral protein in death receptor-associated apoptosis, and loss of caspase 8 via the epigenetic phenomenon of methylation in neuroblastoma has led to increased resistance to chemotherapy. Recent evidence suggests that caspase 8 loss may also contribute to a metastatic phenotype; thus, caspase 8 may prove to be an attractive target for therapy both in treating primary tumours as well as preventing and treating metastatic lesions. Numerous methods have been described to manipulate caspase 8 levels both in vitro and in vivo, and investigation into caspase 8 isoforms may also bring forth additional therapeutic targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据